Craig-Hallum analyst Albert Lowe maintained a Buy rating on Eupraxia Pharmaceuticals (EPRX – Research Report) today. The company’s shares ...

The business, which provides filters for the purification of food or beverages and drugs during development, brought in about $1 billion in revenue in 2024, Thermo said. Evercore analyst Vijay ...

RXRX is expected to provide updates on its oncology and rare disease pipeline in its fourth-quarter earnings release, given ...

Filter, analyze, and streamline your search ... s best-performing stocks on TipRanks >> Read More on CPRX: Catalyst Pharmaceutical Partners NewsMORE Related Stocks Indices Commodities Currencies ...

the filter user will be thoroughly analyzed. PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.

Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...

Pharmaceutical facilities must accommodate ... This includes systems to prevent contamination, such as advanced ventilation and filtration, and the use of carefully selected materials resistant ...

AbbVie, Danaher, Organovo, Thermo Fisher Scientific, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of ...